Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

i-DEF Investigators

Research output: Contribution to journalArticlepeer-review

88 Scopus citations

Fingerprint

Dive into the research topics of 'Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences